Sharekhan

Amrutanjan Health Care Ltd

Thu 13/03/2025,15:51:5 | NSE : AMRUTANJAN

₹ 589.10-0.60 (-0.10%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 595.00

Previous Close

₹ 589.70

Volume

18201

Mkt Cap ( Rs. Cr)

₹1703.13

High

₹ 595.05

Low

₹ 585.00

52 Week High

₹ 862.60

52 Week Low

₹ 559.95

Book Value Per Share

₹ 103.00

Dividend Yield

0.78

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Amrutanjan Health Care Ltd

Your Vote -

Buy

84.38%

Hold

9.38%

Sell

6.25%

84.38%

32 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Amrutanjan Health Care Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Amrutanjan Health Ca - Disclosure Under Regulation 30 Of SEBI LODR 2015

    3 Mar 2025, 6:55PM Disclosure under Regulation 30 of SEBI LODR 2015
  • Amrutanjan Health Ca - Disclosure Under Regulation 30 Of SEBI LODR 2015

    3 Mar 2025, 6:53PM Disclosure under Regulation 30 of SEBI LODR 2015
  • Amrutanjan Health Ca - Action(s) initiated or orders passed

    3 Mar 2025, 6:48PM Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed
  • Amrutanjan Health Ca - Action(s) initiated or orders passed

    3 Mar 2025, 6:46PM Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed
  • Amrutanjan Health Ca - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Feb 2025, 8:01PM Investor Presentation
  • Amrutanjan Health Ca - Investor Presentation

    14 Feb 2025, 7:54PM Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
  • Amrutanjan Health Ca - Copy of Newspaper Publication

    14 Feb 2025, 4:34PM Amrutanjan Health Care Limited has informed the Exchange about Copy of Newspaper Publication
  • Amrutanjan Health Ca has declared 100% Interim dividend for the financial year March 2025

    14 Feb 2025, 7:03AM Amrutanjan Health Care Ltd. on Wednesday, 12 February 2025, has announced Interim dividend of 100 percent on Equity Share, to its shareholders holding
  • Amrutanjan Health Ca - Record Date

    12 Feb 2025, 5:54PM Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Feb-2025.
  • Amrutanjan Health Ca - Outcome of Board Meeting-XBRL

    12 Feb 2025, 5:14PM AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 12-Feb-2025 for Dividend
  • Amrutanjan Health Ca - Integrated Filing- Financial

    12 Feb 2025, 5:07PM Integrated Financials
  • Amrutanjan Health Ca - Financial Result Updates

    12 Feb 2025, 4:53PM Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Amrutanjan Health Ca - Dividend

    12 Feb 2025, 4:52PM Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on February 12, 2025, declared Interim Dividend o
  • Amrutanjan Health Ca - Intimation Of Record Date For The Second Interim Dividend.

    12 Feb 2025, 5:57PM Intimation of Record date for the second interim dividend.
  • Amrutanjan Health Ca Q3 net profit up 10.32% at Rs 19.25 cr

    12 Feb 2025, 5:20PM The company reported standalone net profit of Rs 19.25 crore for the quarter ended December 31, 2024 as compared to Rs 17.45 crore in the same period
  • Amrutanjan Health Ca - Integrated Filing (Financial)

    12 Feb 2025, 5:09PM Integrated Filing
  • Amrutanjan Health Ca - Unaudited Financial Results For The Quarter Ended December 31, 2024.

    12 Feb 2025, 5:01PM Unaudited Financial results for the quarter ended December 31, 2024.
  • Amrutanjan Health Ca - Board Meeting Outcome for Outcome Of Board Meeting Held On February 12, 2025.

    12 Feb 2025, 4:57PM Outcome of Board Meeting.
  • Amrutanjan Health Ca - Board Meeting Intimation

    31 Jan 2025, 5:14PM AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited
  • Amrutanjan Health Ca - Board Meeting Intimation for Unaudited Finacial Results For The Quarter Ended 31St December 2024 And 2

    31 Jan 2025, 3:55PM AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to cons
  • Amrutanjan Health Ca has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    17 Jan 2025, 7:30PM As of December 2024, 46.52% is owned by Indian Promoters, 53.44% by Public and 0.04% by Non Promoters-Non Public. <p align=justify> Top five Promoters
  • Amrutanjan Health Ca - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2025, 5:16PM Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Amrutanjan Health Ca - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2025, 5:04PM Compliance Certificate under Reg 74(5) of SEBI DP Regulation
  • Amrutanjan Health Ca - Trading Window-XBRL

    26 Dec 2024, 3:59PM AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange about Closure of Trading Window
  • Amrutanjan Health Ca - Trading Window

    26 Dec 2024, 3:47PM Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula
  • Amrutanjan Health Care surges as board nod buyback of shares

    30 Jun 2023 , 11:49AM Amrutanjan Health Care rises by 16% to Rs. 774.75, as board approves buyback of shares worth Rs. 28.8 Crore
  • Amrutanjan Heath Care signs up with Amazon

    27 Aug 2018 , 3:31PM Amrutanjan Heath Care signs up with Amazon to offer Amrutanjan products from August 18, 2018

Key fundamentals

Evaluate the intrinsic value of Amrutanjan Health Care Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 288.4883 290.7719 265.1238 215.5647 159.4256
Liabilities 288.4883 290.7719 265.1238 215.5647 159.4256
Equity 2.8911 2.9231 2.9231 2.9231 2.9231
Gross Profit 51.8114 44.3923 79.4738 74.7541 30.713
Net Profit 44.9726 39.8349 67.1889 61.1904 25.0833
Cash From Operating Activities 27.9106 20.181 52.1956 89.7638 18.1761
NPM(%) 10.67 10.49 16.55 18.38 9.59
Revenue 421.2305 379.636 405.8424 332.844 261.4767
Expenses 369.4191 335.2437 326.3686 258.0899 230.7637
ROE(%) 15.1 13.37 22.56 20.54 8.42

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Feb 2025 1 100 0.78 621.7
22 Nov 2024 1 100 0.78 743.65
13 Sep 2024 2.6 260 0.78 736.55
20 Feb 2024 1 100 0.78 572.85
24 Feb 2023 1 100 0.78 710.9
14 Sep 2022 2.6 260 0.78 824.4
18 Feb 2022 1 100 0.78 853.5
16 Nov 2021 1 100 0.78 923.45
15 Sep 2021 2.6 260 0.78 760.45
17 Feb 2021 0.8 80 0.78 519.45
19 Nov 2020 0.8 80 0.78 427.35
18 Feb 2020 1.55 155 0.78 481.2
15 Nov 2019 0.55 55 0.78 409.8
17 Sep 2019 1.05 105 0.78 283.65
20 Feb 2019 0.55 55 0.78 312
12 Nov 2018 0.55 55 0.78 244.45
07 Sep 2018 0.85 85 0.78 280.55
22 Feb 2018 1.1 55 0.78 590.75
16 Nov 2017 1.1 55 0.78 590.55
13 Sep 2017 1.65 82.5 0.78 767.9
16 Feb 2017 1.1 55 0.78 605.35
17 Nov 2016 1.1 55 0.78 576.15
18 Mar 2016 2.65 132.5 0.78 406.6
17 Feb 2016 1.2 60 0.78 422.65
10 Sep 2015 2.4 120 0.78 483.65
13 Feb 2015 1.1 55 0.78 430.15
17 Sep 2014 2.2 110 0.78 155.55
17 Feb 2014 1 50 0.78 132.2
02 Aug 2013 2 100 0.78 132.85
21 Feb 2013 1 50 0.78 141.55
20 Sep 2012 10 100 0.78 772.6
23 Feb 2012 5 50 0.78 818.15
12 Sep 2011 10 100 0.78 831.45
21 Feb 2011 5 50 0.78 560.2
13 Aug 2010 10 100 0.78 807.15
09 Feb 2010 5 50 0.78 545.35

Peers

Other companies within the same industry or sector that are comparable to Amrutanjan Health Care Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 335.78 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 1223.55 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 630.66 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 1153.70 -239.30 0.00

Company Info

The Company was incorporated in 1936. The company manufactures, Amrutanjan pain balm, Anoleum, Gripe Water, Inhaler, Dermal Ointment, Cetomix cough mixture, Castor Oil, Swas Mints 'Salofin' tablets, Amrutanjan cold rub, 'Hero' Super Pain Balm, Dragon Liquid Balm. The company has concluded an arrangement for marketing of "Gelax" and Anchor brands of Isabgol with M/s Unjha Formulations in southern states as well as North Eastern parts of the country. Amrutanjan Leasing & Finance Ltd & Amrutanjan Fine Chemicals Ltd are the subsidiary companies. 2001- Amrutanjan has announced a liberal bonus issue by capitalising Rs 1.6 crore reserve for the benefit of small shareholders. 2004 -Winds up its printing and packaging arm, Egattur Printing and Packaging Ltd 2007 - Company name has been changed from Amrutanjan Ltd to Amrutanjan Health Care Ltd. 2009 - Amrutanjan Health Care Ltd has informed that the Board of Directors of the Company at its meeting held on June 25, 2009 has co-opted Mr. A Satish Kumar as an Additional Director of the Company under Section 260 of the Companies Act, 1956 with effect from June 25, 2009. 2010 -Amrutanjan Health recommend payment of Final Dividend of Rs. 10/- per share (100%) on the Equity Share 2011 -Amrutanjan acquires Fruitnik for Rs 26.2 crore 2012 -Amrutanjan Health Care has recommended a Final Dividend of Rs. 10/- per share -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 -Board has recommended a Final Dividend of Rs. 2/- per share. 2014 -Board has recommended a Final Dividend of Rs. 2.20/- (110%) per share. 2016 -Amrutanjan Health Care Limited has informed that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee) was approved by the National Company law Tribunal (NCLT) , Chennai 2017 -Company Informed to exchange that NCLT has approved the Amalgamation of Amrutanjan Pharmaessense Private Limited with M/s. Amrutanjan Health Care Limited. 2018 -The Company has splits its face value from Rs. 2/- to Rs. 1/-. -Company Won Best Brand Leadership Awards, 2018.

The Company was incorporated in 1936. The company manufactures, Amrutanjan pain balm, Anoleum, Gripe Water, Inhaler, Dermal Ointment, Cetomix cough mixture, Castor Oil, Swas Mints 'Salofin' tablets, Amrutanjan cold rub, 'Hero' Super Pain Balm, Dragon Liquid Balm. The company has concluded an arrangement for marketing of "Gelax" and Anchor brands of Isabgol with M/s Unjha Formulations in southern states as well as North Eastern parts of the country. Amrutanjan Leasing & Finance Ltd & Amrutanjan Fine Chemicals Ltd are the subsidiary companies. 2001- Amrutanjan has announced a liberal bonus issue by capitalising Rs 1.6 crore reserve for the benefit of small shareholders. 2004 -Winds up its printing and packaging arm, Egattur Printing and Packaging Ltd 2007 - Company name has been changed from Amrutanjan Ltd to Amrutanjan Health Care Ltd. 2009 - Amrutanjan Health Care Ltd has informed that the Board of Directors of the Company at its meeting held on June 25, 2009 has co-opted Mr. A Satish Kumar as an Additional Director of the Company under Section 260 of the Companies Act, 1956 with effect from June 25, 2009. 2010 -Amrutanjan Health recommend payment of Final Dividend of Rs. 10/- per share (100%) on the Equity Share 2011 -Amrutanjan acquires Fruitnik for Rs 26.2 crore 2012 -Amrutanjan Health Care has recommended a Final Dividend of Rs. 10/- per share -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 -Board has recommended a Final Dividend of Rs. 2/- per share. 2014 -Board has recommended a Final Dividend of Rs. 2.20/- (110%) per share. 2016 -Amrutanjan Health Care Limited has informed that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee) was approved by the National Company law Tribunal (NCLT) , Chennai 2017 -Company Informed to exchange that NCLT has approved the Amalgamation of Amrutanjan Pharmaessense Private Limited with M/s. Amrutanjan Health Care Limited. 2018 -The Company has splits its face value from Rs. 2/- to Rs. 1/-. -Company Won Best Brand Leadership Awards, 2018.

Read More

Parent Organisation

Amrutanjan Health Care Ltd.

Founded

09/09/1936

Managing Director

Mr.S Sambhu Prasad

NSE Symbol

AMRUTANJANEQ

FAQ

The current price of Amrutanjan Health Care Ltd is ₹ 589.10.

The 52-week high for Amrutanjan Health Care Ltd is ₹ 595.05 and the 52-week low is ₹ 585.00.

The market capitalization of Amrutanjan Health Care Ltd is currently ₹ 1703.13. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Amrutanjan Health Care Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Amrutanjan Health Care Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Amrutanjan Health Care Ltd shares.

The CEO of Amrutanjan Health Care Ltd is Mr.S Sambhu Prasad, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT